Advancing the global public health agenda for NAFLD: a consensus statement JV Lazarus, HE Mark, QM Anstee, JP Arab, RL Batterham, L Castera, ... Nature Reviews Gastroenterology & Hepatology 19 (1), 60-78, 2022 | 462 | 2022 |
The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge? JV Lazarus, HE Mark, M Villota-Rivas, A Palayew, P Carrieri, M Colombo, ... Journal of hepatology 76 (4), 771-780, 2022 | 175 | 2022 |
Treating chronic hepatitis delta: the need for surrogate markers of treatment efficacy C Yurdaydin, Z Abbas, M Buti, M Cornberg, R Esteban, O Etzion, EJ Gane, ... Journal of Hepatology 70 (5), 1008-1015, 2019 | 119 | 2019 |
Clinical and virological heterogeneity of hepatitis delta in different regions world‐wide: the Hepatitis Delta International Network (HDIN) A Wranke, LM Pinheiro Borzacov, R Parana, C Lobato, S Hamid, ... Liver International 38 (5), 842-850, 2018 | 100 | 2018 |
A global research priority agenda to advance public health responses to fatty liver disease JV Lazarus, HE Mark, AM Allen, JP Arab, P Carrieri, M Noureddin, ... Journal of hepatology 79 (3), 618-634, 2023 | 38 | 2023 |
Hepatitis Delta International Network. Clinical and virological heterogeneity of hepatitis delta in different regions world-wide: The Hepatitis Delta International Network (HDIN) A Wranke, LM Pinheiro Borzacov, R Parana, C Lobato, S Hamid, ... Liver Int 38 (5), 842-50, 2018 | 25 | 2018 |
Profile of hepatocellular carcinoma in the Republic of Moldova: first-hand information on the presentation, distribution and etiologies A Turcanu, E Pitel, VT Dumbrava, E Tcaciuc, A Donscaia, A Peltec, ... Romanian Journal of Internal Medicine 57 (1), 37-46, 2019 | 15 | 2019 |
Week 48 results of the phase 3 D-LIVR study, a randomized double-blind, placebo-controlled trial evaluating the safety and efficacy of lonafarnib-boosted with ritonavir with or … O Etzion, SS Hamid, T Asselah, GS Gherlan, A Turcanu, T Petrivna, ... J Hepatol 78 (suppl 1), S10, 2023 | 9 | 2023 |
Problemele flebologiei chirurgicale la etapa actuală D Tabac, A Castraveţ, A Ţurcanu, V Ghiţu, V Iachim, E Bernaz Rezumatul lucrărilor Congresului al IX lea al asociaţiei Chirurgilor „N …, 2003 | 5 | 2003 |
In Moldova, social situation is a primary modulator of survival in a hepatocellular carcinoma A Turcanu, P Pineau, E Tcaciuc, VT Dumbrava Journal of Hepatology 68, S442-S443, 2018 | 4 | 2018 |
Scorurile prognostice a riscului de mortalitate la pacienții din lista de așteptare pentru transplantul hepatic V Spinei, E Tcaciuc, E Berliba, A Ţurcanu, N Taran, G Ivancov, ... Buletinul Academiei de Ştiinţe a Moldovei. Ştiinţe Medicale 62 (2), 135-141, 2019 | 3 | 2019 |
Diversity of clinical presentation and virological characterics of hepatitis delta in diferent regions worl-wide: results of hepatitis delta International Network A Wranke, S Hardtke, LM Borzacov, R Parana, CMDO Lobato, SS Hamid, ... Journal of Hepatology 66 (S1), S257-S258, 2017 | 3 | 2017 |
Diversity of clinical presentation and virological characteristics of hepatitis delta: The hepatitis Delta International network (HDIN) A Wranke, S Hardtke, LMP Borzacov, R Parana, C Lobato, S Hamid, ... Zeitschrift für Gastroenterologie 54 (12), A5. 12, 2016 | 3 | 2016 |
The “Mimic” liver disease in Wilson’s disease A Ţurcanu Sănătate Publică, Economie şi Management în Medicină 61 (4), 74-76, 2015 | 3 | 2015 |
Autoimmune hepatitis guidelines for students E Berliba, A Turcanu CEP" Medicina", 2014 | 3 | 2014 |
Boala ficatului gras non-alсooliс. Mеtodе non-invazivе de diagnostic P Namolovan, E Tcaciuc, E Berliba, S Ţurcan, L Tofan-Scutaru, A Ţurcanu, ... Buletinul Academiei de Ştiinţe a Moldovei. Ştiinţe Medicale 62 (2), 177-184, 2019 | 2 | 2019 |
Hepatopatia cronică virală Delta: de la hepatită cronică la carcinom hepatocelular A Ţurcanu | 2 | 2018 |
Metodele invazive în diagnosticul infecției cu helicobacter pylori–mijloace eficiente ce sporesc rata de eradicare D Chiriac, A Ţurcanu, E Berliba, L Tofan-Scutaru, E Tcaciuc, A Peltec Buletinul Academiei de Ştiinţe a Moldovei. Ştiinţe Medicale 55 (3), 48-53, 2017 | 2 | 2017 |
Role of spirulin derivate drug in the dynamics of chronic hepatitis B and C AI Turcanu Journal of clinical and experimental hepatology 3 (1), S44-S45, 2013 | 2 | 2013 |
Hepatocellular carcinoma in HDV infected patients from Republic of Moldova: from risk factors to survival A Ţurcanu Eurasian journal of clinical sciences 2 (2), 1-1, 2019 | 1 | 2019 |